KAPTIRON®

Kaptiron® is indicated for the treatment of chronic iron overload secondary to frequent blood transfusions, in patients 6 years of age and older with beta-thalassemia major, it is also indicated for the treatment of secondary chronic iron overload. to blood transfusions when treatment with deferoxamine is contraindicated or unsuitable. As indicated on the instructions

Additional information

DCI

DEFERASIROX

Dosage

250 mg

Trade name

KAPTIRON®

Name of the originator

EXJADE ®

Presentation

30 tablets

Specialty

Chélateur de fer

See also